SELLAS Life Sciences Group, Inc. (SLS)

Many, many, catalysts in place for SLS including a new cancer treatment drug, co-developed by MERCK, now entering phase III FDA testing.
Additional round of S-1 financing was completed in under FOUR days! Meaning some entity(s) really really wanted to scoop up as much SLS as possible... quite possibly MERCK.

As you can see, the recent low was established on July 1st at .1021.
Then a nearly 200% gain sent the PPS soaring up to .2880.
This was followed by a smooth decline where it bottomed out at .1200.
And earlier this week it rose (once again, the change was nice & smooth) to .2489.
These changes formed the cup.

Now the PPS has leveled out at a new bottom of roughly .1600, which is up from the recent low as well as the low point in the cup.
Together, you have a textbook Cup and Handle chart.
The next run should be significantly higher than the high of the cup's lips, which was .2880
Additional indicators show that a reversal back up in taking place.